HASENTECH, INC.
Biotech · Private
Dendritic cell therapy (EPS-DCs) derived from probiotic exopolysaccharide-treated cells to prevent graft-versus-host disease in hematopoietic stem cell transplantation
- Grants
- $899K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Prevention of GVHD by a probiotic exopolysaccharide. | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Dendritic cell therapy for GvHD | $299,989 | |
| Federal grant | Department of Health and Human Services · Phase I · Dendritic cell therapy for GvHD | $298,956 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2054 | Advanced Solutions Holdings, Inc. | — | $36M |
| 2055 | CATENA BIOSCIENCES, INC. | — | — |
| 2056 | Aspen Stem Cell Institute, LLC | — | — |
| 2057 | HASENTECH, INC. | — | — |
| 2058 | SAB CAPRA, LLC | — | — |
| 2059 | Angitia Biopharmaceuticals | — | — |
| 2060 | RADTRAN LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.